Chronic stable angina: percutaneous coronary intervention or medication? 2011

Dimitrios Maragiannis, and George Lazaros, and Manolis Vavuranakis, and Christina Chrysohoou, and Stavroula Athanassopoulou, and Athanassios Patialiakas, and Christodoulos Stefanadis
1st Cardiology Department, School of Medicine, University of Athens, Hippokration Hospital, Athens, Greece. glaz35@hotmail.com

UI MeSH Term Description Entries
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000787 Angina Pectoris The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION. Angor Pectoris,Stenocardia,Stenocardias
D015906 Angioplasty, Balloon, Coronary Dilation of an occluded coronary artery (or arteries) by means of a balloon catheter to restore myocardial blood supply. Angioplasty, Coronary Balloon,Angioplasty, Transluminal, Percutaneous Coronary,Coronary Angioplasty, Transluminal Balloon,Percutaneous Transluminal Coronary Angioplasty,Balloon Dilation, Coronary Artery,Transluminal Coronary Balloon Dilation,Angioplasties, Coronary Balloon,Balloon Angioplasties, Coronary,Balloon Angioplasty, Coronary,Coronary Balloon Angioplasties,Coronary Balloon Angioplasty
D019161 Hydroxymethylglutaryl-CoA Reductase Inhibitors Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. HMG-CoA Reductase Inhibitor,HMG-CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Reductase Inhibitor,Statin,Statins, HMG-CoA,Inhibitors, HMG-CoA Reductase,Inhibitors, Hydroxymethylglutaryl-CoA,Inhibitors, Hydroxymethylglutaryl-Coenzyme A,Statins,HMG CoA Reductase Inhibitor,HMG CoA Reductase Inhibitors,HMG-CoA Statins,Hydroxymethylglutaryl CoA Reductase Inhibitor,Hydroxymethylglutaryl CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Inhibitors,Hydroxymethylglutaryl-Coenzyme A Inhibitors,Inhibitors, HMG CoA Reductase,Inhibitors, Hydroxymethylglutaryl CoA,Inhibitors, Hydroxymethylglutaryl Coenzyme A,Inhibitors, Hydroxymethylglutaryl-CoA Reductase,Reductase Inhibitor, Hydroxymethylglutaryl-CoA,Reductase Inhibitors, HMG-CoA,Reductase Inhibitors, Hydroxymethylglutaryl-CoA,Statins, HMG CoA

Related Publications

Dimitrios Maragiannis, and George Lazaros, and Manolis Vavuranakis, and Christina Chrysohoou, and Stavroula Athanassopoulou, and Athanassios Patialiakas, and Christodoulos Stefanadis
June 2010, The American journal of the medical sciences,
Dimitrios Maragiannis, and George Lazaros, and Manolis Vavuranakis, and Christina Chrysohoou, and Stavroula Athanassopoulou, and Athanassios Patialiakas, and Christodoulos Stefanadis
February 2008, JACC. Cardiovascular interventions,
Dimitrios Maragiannis, and George Lazaros, and Manolis Vavuranakis, and Christina Chrysohoou, and Stavroula Athanassopoulou, and Athanassios Patialiakas, and Christodoulos Stefanadis
February 2018, The American journal of nursing,
Dimitrios Maragiannis, and George Lazaros, and Manolis Vavuranakis, and Christina Chrysohoou, and Stavroula Athanassopoulou, and Athanassios Patialiakas, and Christodoulos Stefanadis
August 2010, Evidence-based medicine,
Dimitrios Maragiannis, and George Lazaros, and Manolis Vavuranakis, and Christina Chrysohoou, and Stavroula Athanassopoulou, and Athanassios Patialiakas, and Christodoulos Stefanadis
July 2018, Lancet (London, England),
Dimitrios Maragiannis, and George Lazaros, and Manolis Vavuranakis, and Christina Chrysohoou, and Stavroula Athanassopoulou, and Athanassios Patialiakas, and Christodoulos Stefanadis
July 2018, Lancet (London, England),
Dimitrios Maragiannis, and George Lazaros, and Manolis Vavuranakis, and Christina Chrysohoou, and Stavroula Athanassopoulou, and Athanassios Patialiakas, and Christodoulos Stefanadis
July 2018, Lancet (London, England),
Dimitrios Maragiannis, and George Lazaros, and Manolis Vavuranakis, and Christina Chrysohoou, and Stavroula Athanassopoulou, and Athanassios Patialiakas, and Christodoulos Stefanadis
July 2018, Lancet (London, England),
Dimitrios Maragiannis, and George Lazaros, and Manolis Vavuranakis, and Christina Chrysohoou, and Stavroula Athanassopoulou, and Athanassios Patialiakas, and Christodoulos Stefanadis
July 2018, Lancet (London, England),
Dimitrios Maragiannis, and George Lazaros, and Manolis Vavuranakis, and Christina Chrysohoou, and Stavroula Athanassopoulou, and Athanassios Patialiakas, and Christodoulos Stefanadis
July 2018, Lancet (London, England),
Copied contents to your clipboard!